Prolonged enoxaparin therapy compared with standard-of-care antithrombotic therapy in opiate-treated patients undergoing primary percutaneous coronary intervention

A novel enoxaparin regimen consisting of intra-arterial bolus (0.75 mg/kg) followed by intravenous infusion (0.75 mg/kg/6 hours) has been developed as a possible solution to the delayed absorption of oral P2Y(12) inhibitors in opiate-treated ST-elevation myocardial infarction (STEMI) patients underg...

Descripción completa

Detalles Bibliográficos
Autores principales: Sumaya, Wael, Parker, William A.E., Judge, Heather M., Hall, Ian R., Orme, Rachel C., Adam, Zulfiquar, Richardson, James D., Rothman, Alexander M.K., Morgan, Kenneth P., Gunn, Julian P., Storey, Robert F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352377/
https://www.ncbi.nlm.nih.gov/pubmed/32543247
http://dx.doi.org/10.1080/09537104.2020.1779925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352377/
https://www.ncbi.nlm.nih.gov/pubmed/32543247
http://dx.doi.org/10.1080/09537104.2020.1779925

Ejemplares similares